Scoping Review of Definitions of Chronic Kidney Disease in Randomized Controlled Trials of SGLT-2 Inhibitors in People with Kidney Disease and Diabetes
Abstract
To better understand how clinical trials of SGLT-2 inhibitors report on and assess the outcomes for the CKD population, we aim to conduct a scoping review to identify the definitions and categories of CKD reported in the publications of these studies.
Fields of Study & Subjects
Chronic Kidney Disease and Diabetes
Diabetes Treatment and Management
Acute Kidney Injury Research
Publication details
- Publication date
- 1 January 2026
- Document type
- Preprint